|

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

RECRUITINGSponsored by The University of Texas Health Science Center at San Antonio
Actively Recruiting
SponsorThe University of Texas Health Science Center at San Antonio
Started2019-09-13
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03894917

Summary

This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Histologically or radiographically (CT or MRI) confirmed newly diagnosed hepatocellular carcinoma.
* Age 18 years and older.
* Patients with advanced, unresectable HCC as determined by the treating physician.

Exclusion Criteria:

* Patients with resectable HCC who are still candidates for locoregional therapy
* Patients receiving prior systemic or locoregional therapy

Conditions4

CancerCarcinoma, HepatocellularLiver CancerLiver Disease

Locations1 site

Mays Cancer Center
San Antonio, Texas, 78229
Gina Alvarez, RN210-450-5893alvarezg1@uthscsa.edu

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.